Canopy Growth Corporation Common Shares (CGC) Financial Statements
Historical financial data — 21 statements covering FY2020–FY2026
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of dist...
Canopy Growth Corporation Common Shares's revenue increased 5.8% year over year, from $269.0M to $284.6M.
Net income increased 56.0% over the same period, from $-598.1M to $-262.9M.
Over the 6-year period from FY2020 to FY2026, revenue declined by 29% in total.
Total debt decreased by 27.6% to $217.1M.
The debt-to-equity ratio stands at 0.31, indicating a moderate leverage profile.
Operating cash flow grew 61.5% to $-63.8M.
Canopy Growth Corporation Common Shares maintains a negative net profit margin of -92.4%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2024 | $66.2M-10.2% | $-127.1M | $23.0M | $-29.1M | $-51.8M | $1.29B | $558.5M | $532.9M |
| Q2 FY2025 | $129.2M+95.1% | $-255.4M | $44.9M | $-75.1M | $-105.6M | $1.23B | $415.9M | $509.7M |
| Q3 FY2025 | $74.8M-42.1% | $-121.9M | $24.1M | $-23.8M | $-27.0M | $1.16B | $438.4M | $591.5M |
| Q4 FY2025 | $65.0M-13.0% | $-220.8M | $10.5M | $-18.3M | $-33.2M | $917.7M | $299.8M | $487.2M |
| Q1 FY2026 | $72.1M+10.9% | $-41.5M | $18.0M | $-22.6M | $-10.3M | $904.7M | $289.0M | $489.0M |
| Q2 FY2026 | $66.7M-7.6% | $-1.6M | $21.9M | $-16.9M | $-18.0M | $1.07B | $226.3M | $736.0M |
| Q3 FY2026 | $74.5M+11.8% | $-62.6M | $21.5M | $-26.4M | $-17.2M | $1.11B | $225.0M | $758.2M |
| Q4 FY2026 | $71.2M-4.4% | $-157.1M | $8.3M | $-95.8M | $-18.3M | $1.12B | $217.1M | $697.6M |
Balance Sheet Summary (FY2026)
Canopy Growth Corporation Common Shares (CGC) Financial Statements & Revenue History
Canopy Growth Corporation Common Shares (CGC) is a US-listed stock operating in the Healthcare sector, specifically the Medicinal Chemicals & Botanical Products industry trading at $0.72 with a market capitalization of $0. This page provides 21 historical financial statements for Canopy Growth Corporation Common Shares, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Canopy Growth Corporation Common Shares reported revenue of $285 million, representing 5.8% year-over-year growth. The net profit margin of -92.4% indicates the company is currently unprofitable. The debt-to-equity ratio of 0.31 shows conservative leverage.
CGC Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Canopy Growth Corporation Common Shares's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether CGC is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track CGC's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Canopy Growth Corporation Common Shares converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of CGC's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use CGC Financial Data
Investors use Canopy Growth Corporation Common Shares's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare CGC's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how CGC's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View CGC's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Canopy Growth Corporation Common Shares's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.CGC trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.